الفهرس 
GlaucomaOnly 14 pages are availabe for public view
 |  | from | 198 |  |  |
| | | from | 198 | | |
Abstract
Introduction: Glaucoma is a chronic, degenerative optic neuropathy, which cause progressive damage to the optic nerve, retinal ganglion cell death and characteristic damage to the visual field.
Stem cells are cells that not yet specialized, they have two important characteristics that distinguish them from other types of cells; first they are unspecialized cells that renew themselves through cell division, second is that under certain physiological or experimental conditions they can be induced to become cells with special function.
Aim of the Work: Review literature to discuss the new strategies in the treatment of glaucoma by using stem cells.
Conclusion: The use of stem cells in the clinical therapy of glaucoma will be an important step in the future as it will transform present-day treatment with the hope of restoring sight to patients with glaucoma. It is important to recognize that whatever contribution stem cell transplantation may make in the future to the management of glaucoma, it must be carried out in conjunction with IOP reduction. Combination therapies are likely to be efficacious in preventing vision loss in glaucoma, and ideally multiple, synergistic avenues for glaucoma treatment will be available in the future. Moreover, even if RGC replacement is one day feasible, IOP must be effectively and continually managed to prevent glaucomatous degeneration of the replacement RGCs.